Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lebowitz

Showing results (1031-1040 of 1,066) with videos related to

Pageof 107
Sort By:
Lancet (London, England)|May 22, 2012
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trialGerald S Falchook, Georgina V Long, Razelle Kurzrock, et al.
The American Journal of Psychiatry|November 1, 2006
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D reportA John Rush, Madhukar H Trivedi, Stephen R Wisniewski, et al.
Journal of Anxiety Disorders|March 21, 2025
Computationally derived parent-child interaction patterns and oxytocin in children with and without OCDAnna-Rosa Cecilie Mora-Jensen, Christine Lykke Thoustrup, Eli R Lebowitz, et al.
Journal of Pain and Symptom Management|January 15, 2022
Reliability and Validity of the Japanese Pediatric Version of Memorial Symptom Assessment ScaleTomomi Hayase, Makiko N Mieno, Kyoko Kobayashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2014
Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436)Gerald S Falchook, Georgina V Long, Razelle Kurzrock, et al.
Diabetes|May 26, 2021
Monogenic Diabetes and Integrated Stress Response Genes Display Altered Gene Expression in Type 1 DiabetesHelmut Hiller, Dawn E Beachy, Joseph J Lebowitz, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 12, 2001
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodologyL S Schneider, P N Tariot, C G Lyketsos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2013
Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor dabrafenib (GSK2118436)Katherine L Nathanson, Anne-Marie Martin, Bradley Wubbenhorst, et al.
American Journal of Human Genetics|May 23, 2024
Haploinsufficiency underlies the neurodevelopmental consequences of SLC6A1 variantsDina Buitrago Silva, Marena Trinidad, Alicia Ljungdahl, et al.
The Journal of Biological Chemistry|July 28, 2009
Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidateMatthew L Plassmeyer, Karine Reiter, Richard L Shimp, et al.
Pageof 107

Showing results (1031-1040 of 1,066) with videos related to

Sort By:
Pageof 107
Lancet (London, England)|May 22, 2012
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trialGerald S Falchook, Georgina V Long, Razelle Kurzrock, et al.
The American Journal of Psychiatry|November 1, 2006
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D reportA John Rush, Madhukar H Trivedi, Stephen R Wisniewski, et al.
Journal of Anxiety Disorders|March 21, 2025
Computationally derived parent-child interaction patterns and oxytocin in children with and without OCDAnna-Rosa Cecilie Mora-Jensen, Christine Lykke Thoustrup, Eli R Lebowitz, et al.
Journal of Pain and Symptom Management|January 15, 2022
Reliability and Validity of the Japanese Pediatric Version of Memorial Symptom Assessment ScaleTomomi Hayase, Makiko N Mieno, Kyoko Kobayashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2014
Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436)Gerald S Falchook, Georgina V Long, Razelle Kurzrock, et al.
Diabetes|May 26, 2021
Monogenic Diabetes and Integrated Stress Response Genes Display Altered Gene Expression in Type 1 DiabetesHelmut Hiller, Dawn E Beachy, Joseph J Lebowitz, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 12, 2001
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodologyL S Schneider, P N Tariot, C G Lyketsos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2013
Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor dabrafenib (GSK2118436)Katherine L Nathanson, Anne-Marie Martin, Bradley Wubbenhorst, et al.
American Journal of Human Genetics|May 23, 2024
Haploinsufficiency underlies the neurodevelopmental consequences of SLC6A1 variantsDina Buitrago Silva, Marena Trinidad, Alicia Ljungdahl, et al.
The Journal of Biological Chemistry|July 28, 2009
Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidateMatthew L Plassmeyer, Karine Reiter, Richard L Shimp, et al.
Pageof 107